Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids

被引:22
|
作者
Mallory, S
Sommer, M
Arvin, AM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Immunol Microbiol, Stanford, CA 94305 USA
来源
关键词
D O I
10.1086/514277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contributions of the glycoproteins gI (ORF67) and gE (ORF68) to varicella-zoster virus (VZV) replication were investigated in deletion mutants made by using cosmids with VZV DNA derived from the Oka strain. These experiments demonstrated that gI was not required for VZV replication in vitro but gE appeared to be. Although VZV gI was not required, its deletion or mutation resulted in a significant decrease in infectious virus yields, and it disrupted syncytial formation and altered the conformation and distribution of gE in infected cells. Normal cell-to-cell spread and replication kinetics were restored when gI was expressed from a non-native locus in the VZV genome. The expression of intact gI, the ORF67 gene product, is required for efficient VZV replication.
引用
收藏
页码:S22 / S26
页数:5
相关论文
共 50 条
  • [31] The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator
    Cilloniz, Cristian
    Jackson, Wallen
    Grose, Charles
    Czechowski, Donna
    Hay, John
    Ruyechan, William T.
    JOURNAL OF VIROLOGY, 2007, 81 (02) : 761 - 774
  • [32] VARICELLA-ZOSTER VIRUS (VZV) SPECIFIC CYTOTOXICITY AFTER IMMUNIZATION OF NONIMMUNE ADULTS WITH OKA STRAIN ATTENUATED VZV VACCINE
    HAYWARD, A
    VILLANUEBA, E
    COSYNS, M
    LEVIN, M
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02): : 260 - 264
  • [33] ANTIBODIES TO VARICELLA-ZOSTER VIRUS (VZV) GLYCOPROTEINS (GPS) IN LEUKEMIC CHILDREN (ALL), A FOLLOW-UP-STUDY
    LARUSSA, PS
    STEINBERG, SP
    GERSHON, AA
    PEDIATRIC RESEARCH, 1989, 25 (04) : A183 - A183
  • [34] Polymerase Chain Reaction (PCR) for Varicella Zoster Virus (VZV) in VZV Keratitis
    Crabtree, Gordon
    Vrabec, Tamara
    Baldassano, Vincent D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [35] NEUROPATHOLOGY OF VARICELLA ZOSTER VIRUS(VZV) MYELITIS
    CHO, ES
    PETITO, CK
    DEVINSKY, O
    PRICE, RW
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (03): : 314 - 314
  • [36] STUDY OF VARICELLA-ZOSTER VIRUS (VZV) INFECTIONS IN RENAL-TRANSPLANT RECIPIENTS
    LUBY, JP
    RAMIREZRONDA, CH
    VERGNEMARINI, P
    RINNER, S
    LONG, D
    HULL, A
    CLINICAL RESEARCH, 1976, 24 (01): : A50 - A50
  • [37] Varicella-zoster virus (VZV) infections in HIV-infected children.
    Gershon, A
    Mervish, N
    Larussa, P
    Steinberg, S
    Lo, SW
    Hodes, D
    Fikrig, S
    Bonagura, V
    Bakshi, S
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 119 - 119
  • [38] Characterizing varicella-zoster virus (VZV) latency in an experimental rat model.
    Lee, PJ
    Annunziato, PW
    LaRussa, PS
    Lungu, O
    Steinberg, S
    Silverstein, SJ
    Gershon, AA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 173A - 173A
  • [39] VARICELLA-ZOSTER VIRUS (VZV) REACTIVATION IS RELATED TO THE LOW RESPONSE OF VZV-SPECIFIC IMMUNITY AFTER CHICKENPOX IN INFANCY
    TERADA, K
    KAWANO, S
    YOSHIHIRO, K
    MORITA, T
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03): : 650 - 652
  • [40] Interaction of the bicyclic nucleoside analogues (BCNAs) with human varicella-zoster virus (VZV) and simian varicella virus (SVV) thymidine kinase and VZV DNA polymerase
    Sienaert, R
    Naesens, L
    Luoni, G
    Wathen, M
    Gray, W
    Andrei, G
    Snoeck, R
    De Clercq, E
    McGuigan, C
    Balzarini, J
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A67 - A67